Resveratrol and apoptosis

Hung Yun Lin, Heng Yuan Tang, Faith B. Davis, Paul J. Davis

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Resveratrol is a naturally occurring stilbene with desirable cardioprotective and anti-cancer properties. We have demonstrated the existence of a plasma membrane receptor for resveratrol near the arginine-glycine-aspartate (RGD) recognition site on integrin α vβ 3 that is involved in stilbene-induced apoptosis of cancer cells. Resveratrol treatment in vitro causes activation and nuclear translocation of mitogen-activated protein kinase (ERK1/2), consequent phosphorylation of Ser-15 of p53, and apoptosis. An RGD peptide blocks these actions of resveratrol. By a PD98059-inhibitable process, resveratrol causes inducible COX-2 to accumulate in the nucleus where it complexes with pERK1/2 and p53. Chromatin immunoprecipitation reveals binding of nuclear COX-2 to promoters of certain p53-responsive genes, including PIG3 and Bax. NS-398, a specific pharmacologic inhibitor of COX-2, prevents resveratrol-induced complexing of nuclear ERK1/2 with COX-2 and with pSer-15-p53 and subsequent apoptosis; cyclooxygenase enzyme activity is not involved. Molecular steps in the pro-apoptotic action of resveratrol in cancer cells include induction of intranuclear COX-2 accumulation relevant to activation of p53. Epidermal growth factor, estrogen, and thyroid hormone act downstream of ERK1/2 to prevent resveratrol-induced apoptosis.

Original languageEnglish
Pages (from-to)79-88
Number of pages10
JournalAnnals of the New York Academy of Sciences
Volume1215
Issue number1
DOIs
Publication statusPublished - Jan 2011
Externally publishedYes

Fingerprint

Apoptosis
Stilbenes
Chemical activation
Cells
Neoplasms
Phosphorylation
resveratrol
Cancer
Cyclooxygenase 2 Inhibitors
Chromatin Immunoprecipitation
Mitogen-Activated Protein Kinase 1
p53 Genes
Enzyme activity
Cell membranes
Prostaglandin-Endoperoxide Synthases
Mitogen-Activated Protein Kinases
Thyroid Hormones
Epidermal Growth Factor
Aspartic Acid
Integrins

Keywords

  • Apoptosis
  • COX-2
  • ERK1/2
  • Integrin α β
  • P53
  • Resveratrol

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Resveratrol and apoptosis. / Lin, Hung Yun; Tang, Heng Yuan; Davis, Faith B.; Davis, Paul J.

In: Annals of the New York Academy of Sciences, Vol. 1215, No. 1, 01.2011, p. 79-88.

Research output: Contribution to journalArticle

Lin, Hung Yun ; Tang, Heng Yuan ; Davis, Faith B. ; Davis, Paul J. / Resveratrol and apoptosis. In: Annals of the New York Academy of Sciences. 2011 ; Vol. 1215, No. 1. pp. 79-88.
@article{cf638d21ce324958b7e356a56dd7bd99,
title = "Resveratrol and apoptosis",
abstract = "Resveratrol is a naturally occurring stilbene with desirable cardioprotective and anti-cancer properties. We have demonstrated the existence of a plasma membrane receptor for resveratrol near the arginine-glycine-aspartate (RGD) recognition site on integrin α vβ 3 that is involved in stilbene-induced apoptosis of cancer cells. Resveratrol treatment in vitro causes activation and nuclear translocation of mitogen-activated protein kinase (ERK1/2), consequent phosphorylation of Ser-15 of p53, and apoptosis. An RGD peptide blocks these actions of resveratrol. By a PD98059-inhibitable process, resveratrol causes inducible COX-2 to accumulate in the nucleus where it complexes with pERK1/2 and p53. Chromatin immunoprecipitation reveals binding of nuclear COX-2 to promoters of certain p53-responsive genes, including PIG3 and Bax. NS-398, a specific pharmacologic inhibitor of COX-2, prevents resveratrol-induced complexing of nuclear ERK1/2 with COX-2 and with pSer-15-p53 and subsequent apoptosis; cyclooxygenase enzyme activity is not involved. Molecular steps in the pro-apoptotic action of resveratrol in cancer cells include induction of intranuclear COX-2 accumulation relevant to activation of p53. Epidermal growth factor, estrogen, and thyroid hormone act downstream of ERK1/2 to prevent resveratrol-induced apoptosis.",
keywords = "Apoptosis, COX-2, ERK1/2, Integrin α β, P53, Resveratrol",
author = "Lin, {Hung Yun} and Tang, {Heng Yuan} and Davis, {Faith B.} and Davis, {Paul J.}",
year = "2011",
month = "1",
doi = "10.1111/j.1749-6632.2010.05846.x",
language = "English",
volume = "1215",
pages = "79--88",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Resveratrol and apoptosis

AU - Lin, Hung Yun

AU - Tang, Heng Yuan

AU - Davis, Faith B.

AU - Davis, Paul J.

PY - 2011/1

Y1 - 2011/1

N2 - Resveratrol is a naturally occurring stilbene with desirable cardioprotective and anti-cancer properties. We have demonstrated the existence of a plasma membrane receptor for resveratrol near the arginine-glycine-aspartate (RGD) recognition site on integrin α vβ 3 that is involved in stilbene-induced apoptosis of cancer cells. Resveratrol treatment in vitro causes activation and nuclear translocation of mitogen-activated protein kinase (ERK1/2), consequent phosphorylation of Ser-15 of p53, and apoptosis. An RGD peptide blocks these actions of resveratrol. By a PD98059-inhibitable process, resveratrol causes inducible COX-2 to accumulate in the nucleus where it complexes with pERK1/2 and p53. Chromatin immunoprecipitation reveals binding of nuclear COX-2 to promoters of certain p53-responsive genes, including PIG3 and Bax. NS-398, a specific pharmacologic inhibitor of COX-2, prevents resveratrol-induced complexing of nuclear ERK1/2 with COX-2 and with pSer-15-p53 and subsequent apoptosis; cyclooxygenase enzyme activity is not involved. Molecular steps in the pro-apoptotic action of resveratrol in cancer cells include induction of intranuclear COX-2 accumulation relevant to activation of p53. Epidermal growth factor, estrogen, and thyroid hormone act downstream of ERK1/2 to prevent resveratrol-induced apoptosis.

AB - Resveratrol is a naturally occurring stilbene with desirable cardioprotective and anti-cancer properties. We have demonstrated the existence of a plasma membrane receptor for resveratrol near the arginine-glycine-aspartate (RGD) recognition site on integrin α vβ 3 that is involved in stilbene-induced apoptosis of cancer cells. Resveratrol treatment in vitro causes activation and nuclear translocation of mitogen-activated protein kinase (ERK1/2), consequent phosphorylation of Ser-15 of p53, and apoptosis. An RGD peptide blocks these actions of resveratrol. By a PD98059-inhibitable process, resveratrol causes inducible COX-2 to accumulate in the nucleus where it complexes with pERK1/2 and p53. Chromatin immunoprecipitation reveals binding of nuclear COX-2 to promoters of certain p53-responsive genes, including PIG3 and Bax. NS-398, a specific pharmacologic inhibitor of COX-2, prevents resveratrol-induced complexing of nuclear ERK1/2 with COX-2 and with pSer-15-p53 and subsequent apoptosis; cyclooxygenase enzyme activity is not involved. Molecular steps in the pro-apoptotic action of resveratrol in cancer cells include induction of intranuclear COX-2 accumulation relevant to activation of p53. Epidermal growth factor, estrogen, and thyroid hormone act downstream of ERK1/2 to prevent resveratrol-induced apoptosis.

KW - Apoptosis

KW - COX-2

KW - ERK1/2

KW - Integrin α β

KW - P53

KW - Resveratrol

UR - http://www.scopus.com/inward/record.url?scp=78851471132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78851471132&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2010.05846.x

DO - 10.1111/j.1749-6632.2010.05846.x

M3 - Article

C2 - 21261644

AN - SCOPUS:78851471132

VL - 1215

SP - 79

EP - 88

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -